Apr 30, 2026 06:22AM
Apr 30, 2026 06:00AM
Feb 5, 2026 07:24AM
Jan 8, 2026 12:08PM
Nov 20, 2025 07:45AM
Jul 3, 2025 07:41AM
Jul 3, 2025 07:40AM OS Therapies Granted End of Phase 2 Meeting by US FDA for OST-HER2 Program in the Prevention or Delay of Recurrent, Fully Resected, Pulmonary Metastatic Osteosarcoma
Jun 30, 2025 06:02AM
Jun 30, 2025 06:00AM
Jun 24, 2025 07:41AM
Jun 24, 2025 07:40AM
Jun 23, 2025 08:29PM
Jun 10, 2025 07:40AM
Jun 10, 2025 07:40AM OS Therapies Partners with EVERSANA for the U.S. Commercialization of OST-HER2 in Recurrent, Fully Resected, Pediatric Lung Metastatic Osteosarcoma
Jun 6, 2025 07:31AM
Jun 6, 2025 07:30AM
May 16, 2025 06:00AM
May 15, 2025 06:00AM
May 7, 2025 08:45AM
May 7, 2025 08:45AM
May 2, 2025 09:32AM Emmy-Winning Series Debuts Trailer for "Shelter Me: The Cancer Pioneers" Offering A Hopeful Look at Breakthrough Cancer Therapies
Apr 22, 2025 07:41AM
Apr 22, 2025 07:40AM
Apr 9, 2025 07:40AM
Apr 9, 2025 07:40AM
Apr 7, 2025 06:00AM
Apr 2, 2025 07:40AM
Mar 31, 2025 04:30PM OS Therapies Reports Full Year 2024 Financial Results and Provides Business Update
Mar 31, 2025 07:40AM
Mar 31, 2025 07:40AM
Mar 25, 2025 07:40AM
Mar 13, 2025 07:40AM
Mar 11, 2025 07:40AM
Feb 26, 2025 04:01PM
Feb 24, 2025 07:25AM OS Therapies (OSTX) Forms Subsidiary OS Drug Conjugates and Initiates Review of Strategic Options for its tunable ADC & Drug Conjugates Platforms
Feb 24, 2025 07:25AM
Feb 20, 2025 05:54AM
Feb 20, 2025 05:00AM
Feb 14, 2025 07:36AM
Feb 14, 2025 07:36AM
Feb 4, 2025 07:33AM
Feb 4, 2025 07:33AM OS Therapies Provides Corporate Update
Jan 29, 2025 09:22AM
Jan 15, 2025 07:45AM
Jan 15, 2025 07:40AM
Jan 2, 2025 11:16AM
Dec 31, 2024 03:38PM
Dec 31, 2024 03:38PM
Dec 24, 2024 09:32AM OS Therapies (OSTX) Prices 1.5M Unit Offering at $4/unit
Dec 24, 2024 09:32AM

323,590 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All